DEF: Donaldson Sets 2025 Annual Meeting, Highlights Record Profits

Sentiment:

Proxy Statement


Donaldson Company, Inc. announces its 2025 Annual Meeting of Stockholders, detailing director elections, executive compensation, and auditor ratification, alongside reporting record adjusted operating margin and EPS for fiscal 2025.

Better than expectedAchieved record adjusted operating margin of 15.7% and record adjusted EPS of $3.68, exceeding the annual incentive target for EPS.The Life Sciences segment significantly outperformed its net operating profit and return on investment targets, achieving 374.70% and 360.00% of target, respectively.Sales of approximately $3.7 billion were an all-time high, despite being slightly below the annual incentive target due to softening end-market conditions.

Summary

  • The 2025 Annual Meeting of Stockholders will be held virtually on Friday, November 21, 2025, at 1:00 p.m. (CST), with a record date of September 22, 2025.
  • Stockholders will vote on the election of four directors (Douglas A. Milroy, Richard M. Olson, Jacinth C. Smiley, and new nominee Daniel P. Shine), a non-binding advisory vote on Named Executive Officer compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year ending July 31, 2026.
  • Fiscal 2025 saw record adjusted operating margin of 15.7% and record adjusted EPS of $3.68, with sales reaching an all-time high of approximately $3.7 billion, though sales were below target.
  • The company invested $88 million in R&D and $77 million in capital expenditures during fiscal 2025.
  • Donaldson returned approximately $465 million to stockholders in fiscal 2025, including $132 million in dividends (an increase from $123 million in fiscal 2024) and $334 million in share repurchases (4% of outstanding shares).
  • The executive compensation program is designed to align with long-term stockholder value, with a significant portion of compensation being performance-based and tied to financial measures like net sales, adjusted diluted EPS, and return on investment.
  • The Board of Directors unanimously recommends a vote FOR the election of each director nominee, FOR the compensation of Named Executive Officers, and FOR the ratification of PwC as the independent auditor.

Sentiment

Score: 7

Explanation: The filing highlights strong financial performance with record profits and EPS, consistent shareholder returns through dividends and buybacks, and robust corporate governance. However, sales missed targets due to market conditions, and PSU payouts were below target, tempering overall sentiment from excellent to very good.

Positives

  • Achieved record adjusted operating margin of 15.7% and record adjusted EPS of $3.68 for fiscal 2025.
  • Maintained a consistent cash dividend for 69 years and increased it annually for the past 29 years, securing its position in the S&P High-Yield Dividend Aristocrats Index.
  • Returned a substantial $465 million to stockholders in fiscal 2025 through $132 million in dividends and $334 million in share repurchases.
  • Received strong stockholder support for executive compensation in the 2024 Say-on-Pay vote, with nearly 95% of shares cast in favor.
  • Demonstrated thoughtful investments in R&D ($88 million) and capital expenditures ($77 million) to drive future growth.
  • Made progress on 2030 Sustainability Ambitions, including a newly introduced Waste Reduction Ambition.
  • The Life Sciences segment significantly exceeded its net operating profit and return on investment targets for fiscal 2025, achieving 374.70% and 360.00% of target, respectively.

Negatives

  • Fiscal 2025 sales results of $3.691 billion were below the target of $3.751 billion, attributed to softening select end-market conditions across all segments.
  • Payout for Performance Stock Unit (PSU) awards for the fiscal 2023-2025 cycle was below target at 80.3%, due to Company Net Sales and ROI Incentive being below target.
  • Two Form 4's for Andrew J. Cebulla and one Form 4 for Bradley J. Pogalz were filed late due to administrative delays on the part of the Company, indicating minor Section 16(a) reporting delinquencies.

Risks

  • Strategic and competitive risks are overseen by the Board of Directors.
  • Financial risks are overseen by the Board of Directors.
  • Brand and reputational risks are overseen by the Board of Directors.
  • Legal and regulatory risks are overseen by the Board of Directors.
  • Operational risks are overseen by the Board of Directors.
  • Cybersecurity risk, information security, and technological risk are specifically overseen by the Board and Audit Committee, with regular management updates on identification, assessment, mitigation, and remediation actions.
  • CEO succession planning is overseen by the Board of Directors.
  • Geopolitical risks are overseen by the Board of Directors.

Future Outlook

The company will continue to pursue its 2030 Sustainability Ambitions, including the newly introduced Waste Reduction Ambition. Future executive compensation arrangements will take into account the results of the annual Say-on-Pay advisory vote. PricewaterhouseCoopers LLP has been appointed as the independent registered public accounting firm for the fiscal year ending July 31, 2026.

Management Comments

  • "Fiscal 2025 was a strong year for Donaldson Company. We grew the Company, profitably, through sales of approximately $3.7 billion, an all-time high, record adjusted operating margin of 15.7%, and record adjusted EPS of $3.68. Our teams executed our strategy and delivered for our stakeholders through macroeconomic and cyclical headwinds. We took actions to focus and optimize our expense structure to drive improved efficiency. At the same time, our thoughtful investments for growth continued including R&D expenditures of $88 million and capital expenditures of $77 million. We Advanced Filtration for a Cleaner World and made progress on our 2030 Sustainability Ambitions, including our newly introduced Waste Reduction Ambition."
  • "We continue to return value to our stockholders through dividends and share repurchases. Donaldson has paid a cash dividend every quarter for 69 years and increased the dividend every year for the past 29 years allowing us to maintain our position in the S&P High-Yield Dividend Aristocrats Index. In fiscal 2025, we paid $132 million in dividends, an increase from $123 million in fiscal 2024. In addition, we repurchased 4% of our shares outstanding for $334 million. In total, we returned approximately $465 million to stockholders during fiscal 2025."
  • "The HR Committee believes that this strong support by stockholders reinforces our executive compensation philosophy and the structure of our program, and confirms that it is in alignment with the long-term interests of our stockholders."

Industry Context

The company's fiscal 2025 sales were impacted by "softening select end-market conditions across all segments," suggesting broader macroeconomic or cyclical pressures within the industrial sector. The company benchmarks its executive compensation against a peer group of 20 industrial machinery and related companies, including A. O. Smith, AMETEK, and The Toro Company, indicating its competitive landscape. Its Total Shareholder Return (TSR) is compared against the S&P Industrial Machinery Index, providing a direct industry performance benchmark.

Comparison to Industry Standards

  • Executive compensation elements are generally set around the median of the peer group data and size-adjusted general industry survey data, using a peer group of 20 companies including A. O. Smith Corporation, AMETEK, Inc., Lincoln Electric Holdings, Inc., Nordson Corporation, The Toro Company, and The Timken Company.
  • Stock ownership requirements for officers are set "above-market" compared to common industry practice (e.g., CEO 10 times base salary vs. common 5 times base salary; COO, CFO & Business Presidents 5 times base salary vs. common 3 times base salary).
  • The company's five-year cumulative Total Shareholder Return (TSR) is compared against the S&P Industrial Machinery Index, serving as an industry benchmark for investor returns.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorWillard D. Oberton2025-11-21Not standing for re-election at the end of his term.
Director NomineeDaniel P. Shine2025-11-21New nominee identified by a search firm and evaluated by the Corporate Governance Committee.
Lead DirectorWillard D. Oberton (as Chair of Corporate Governance Committee)Christopher M. Hilger2025-08-01Appointment by the Board, succeeding Mr. Oberton.
President, Enterprise Operations and Supply ChainThomas R. Scalf2025-08-01Retirement from the company.
Chief Operating OfficerRichard B. Lewis (as President, Life Sciences)Richard B. Lewis2025-08-01Appointment to new role.
Chief Financial OfficerScott J. Robinson2024-10-31Resignation from the role, followed by retirement from the company on December 6, 2024.
Chief Financial OfficerBradley J. Pogalz2024-11-01Appointment to the role.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Committee Chair ChangeChristopher M. Hilger succeeded Willard D. Oberton as Chair of the Corporate Governance Committee.2025-08-01Strengthens independent Board leadership with a new Lead Director also chairing a key governance committee.
Board Leadership StructureThe Board maintains a combined Chairman and CEO role (Tod Carpenter), complemented by an independent Lead Director (Christopher Hilger) and independent Board committees.Aims to balance unified leadership with strong independent oversight and transparency.
Risk Oversight AllocationBoard and its committees (Audit, Human Resources, Corporate Governance) are allocated specific risk oversight responsibilities, including cybersecurity, human capital management, and sustainability.Ensures comprehensive and specialized oversight of major risks facing the company.
Director Term/Age LimitsDirectors may not be re-nominated after attaining age 75 or serving for 18 years, unless an exception is approved by the Board.Promotes board refreshment and ensures a balance of experience and new perspectives.
Director Public Company Board LimitsDirectors are limited to serving on a total of five public company boards, or two if serving as a CEO of a public company, including the company's Board.Ensures directors have sufficient time and commitment to fulfill their responsibilities.
Security Trading PolicyProhibition on hedging and pledging company stock for directors, officers, and other employees.Aligns interests of insiders with long-term shareholder value and discourages speculative trading.
Stock Ownership GuidelinesEstablished above-market stock ownership requirements for officers and directors.Further aligns the financial interests of leadership with those of stockholders.
Related Person Transaction PolicyAdopted a written policy delegating review and approval of certain related person transactions to the Audit Committee.Ensures proper oversight and transparency of potential conflicts of interest.
Compensation Recovery PolicyMaintains a Mandatory Compensation Recovery Policy for Section 16 officers and a Supplemental Compensation Recovery Policy for Management Employees (VP and above) for accounting restatements or misconduct.Enhances accountability for financial reporting accuracy and ethical conduct, allowing recovery of erroneously awarded compensation.
Equity Award Vesting PolicyCommencing in fiscal 2025, RSU awards for officers will generally cliff vest after three years, rather than in one-third increments over three years.2024-08-01Reflects a stronger retention purpose for RSU awards.

Legal Proceedings

  • Two Form 4's reporting one transaction each were filed late for Andrew J. Cebulla, and one Form 4 reporting a transaction was filed late for Bradley J. Pogalz, in each case due to administrative delays on the part of the Company, concerning Section 16(a) reports.

Related Party Transactions

  • The company sells products to Cargill, Incorporated, where Pilar Cruz serves as Executive Vice President and Chief Sustainability Officer. Transactions were less than 1% of Cargill's annual revenues.
  • The company purchases products from Securian Financial Group, Inc., where Christopher M. Hilger serves as Chairman, President and Chief Executive Officer. Transactions were less than 1% of Securian Financial Group's annual revenues.
  • The company sells products to The Toro Company, where Richard M. Olson serves as Chairman of Board, President and Chief Executive Officer. Transactions were less than 1% of The Toro Company's annual revenues.
  • The company sells products to and purchases products from Thermo Fisher Scientific, Inc., where Daniel P. Shine serves as Senior Vice President and President, Analytical Instruments. Transactions were less than 1% of Thermo Fisher Scientific's annual revenues.
  • The company sells products to Hormel Foods, where Jacinth C. Smiley serves as Executive Vice President and Chief Financial Officer. Transactions were less than 1% of Hormel Foods' annual revenues.

Stakeholder Impact

  • **Shareholders**: Have the opportunity to exercise their voting rights on critical corporate governance matters, including director elections, executive compensation, and auditor appointment. Benefit from strong financial performance, including record adjusted operating margin and EPS, consistent dividend increases, and significant share repurchases. The sales miss, however, may raise questions about market conditions.
  • **Employees**: Benefit from competitive health and welfare programs, qualified retirement plans, and executive education opportunities for select officers. The HR Committee oversees human capital management and corporate culture, aiming to foster engagement and talent development. Management changes and retirements impact specific individuals.
  • **Customers**: Benefit from the company's continued investments in R&D and capital expenditures, which support innovation and product development. Ordinary course of business transactions with companies where directors serve indicate ongoing commercial relationships.
  • **Management**: Executive compensation is tied to performance, aligning their interests with shareholder value creation, but also subject to rigorous oversight, risk analysis, and recovery policies. New appointments and retirements reflect ongoing succession planning and leadership evolution.

Next Steps

  • Stockholders will vote on the election of directors, the non-binding advisory vote on Named Executive Officer compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm at the Annual Meeting on November 21, 2025.
  • Voting results from the Annual Meeting will be published in a Form 8-K filed with the SEC within four business days of the meeting.
  • The Human Resources Committee and Board will consider the results of the Say-on-Pay vote when determining future executive compensation arrangements.
  • PricewaterhouseCoopers LLP will audit the company's financial statements for the fiscal year ending July 31, 2026.
  • Stockholders wishing to include a proposal in the company's 2026 Annual Meeting Proxy Statement must submit it by June 8, 2026.
  • Stockholders wishing to nominate a director or bring other business before the 2026 Annual Meeting without proxy statement inclusion must notify the Secretary between July 24 and August 23, 2026.
  • Stockholders intending to solicit proxies for director nominees other than the Board's nominees must provide notice by September 22, 2026, to comply with universal proxy rules.

Key Dates

DateDescription
2020-07-31Last day of fiscal 2020, used as base for cumulative Total Shareholder Return (TSR) calculation.
2013-08-01Salaried Employees Pension Plan closed to new participants.
2016-08-01Employees no longer accrue Company contribution credits under the Salaried Employees Pension Plan and Excess Pension Plan.
2020-01-01Effective date for changes to Deferred Compensation and 401(k) Excess Plan, limiting deferral allocation to investment funds and annual installment distributions to 10 years.
2024-01-24BlackRock, Inc. filed Schedule 13G/A.
2024-02-12State Farm Mutual Automobile Insurance filed Schedule 13G/A.
2024-02-13The Vanguard Group, Inc. filed Schedule 13G/A.
2024-07-01HR Committee meeting where the Peer Group was reviewed and discussed.
2024-09-19HR Committee meeting where annual stock option grants were approved.
2024-09-22Record date for the 2025 Annual Meeting of Stockholders.
2024-10-01Annual stock option awards granted to Named Executive Officers.
2024-10-28HR Committee approved an additional stock option award for Mr. Pogalz.
2024-10-31Scott J. Robinson ceased to be Chief Financial Officer at the close of business.
2024-11-01Bradley J. Pogalz appointed Chief Financial Officer.
2024-12-03Company released earnings for the quarter ended October 31, 2024 (pre-market).
2024-12-04Additional stock option award granted to Bradley J. Pogalz.
2024-12-06Scott J. Robinson retired from employment with the Company.
2025-01-01Annual equity value increase for non-employee directors from $150,000 to $170,000 became effective.
2025-07-31End of fiscal year 2025.
2025-08-01Christopher M. Hilger became Lead Director; Richard B. Lewis appointed Chief Operating Officer; Thomas R. Scalf retired.
2025-10-06Mailing date of the Proxy Statement and form of proxy.
2025-11-20Deadline for proxy votes from participants in Donaldson's employee benefit plan.
2025-11-21Date of the 2025 Annual Meeting of Stockholders.
2026-06-08Deadline for stockholders to submit proposals for inclusion in the Company's 2026 Annual Meeting Proxy Statement.
2026-07-24Beginning of the window for stockholders to notify the Secretary in writing for director nominations or other business at the 2026 Annual Meeting (without proxy statement inclusion).
2026-07-31End of fiscal year 2026, for which PricewaterhouseCoopers LLP is appointed independent auditor.
2026-08-23End of the window for stockholders to notify the Secretary in writing for director nominations or other business at the 2026 Annual Meeting (without proxy statement inclusion).
2026-09-22Latest date for stockholders to provide notice under universal proxy rules for the 2026 Annual Meeting.
2027-07-31End of the fiscal 2025-2027 performance cycle for Performance Stock Unit (PSU) awards.
2028-01-01Term expiration for directors elected at the 2025 Annual Meeting.

Recommendation

hold

This filing is a routine proxy statement for the upcoming annual meeting, primarily detailing corporate governance, executive compensation, and director elections. While it reiterates strong fiscal 2025 financial performance, including record adjusted operating margin and EPS, consistent dividends, and significant share repurchases, this information is generally already public and likely priced into the stock. The noted sales miss is also not new information. There are no new material financial disclosures or strategic shifts that would warrant a change in investment stance based solely on this document. The robust corporate governance practices and alignment of executive compensation with shareholder interests are positive but expected for a company of this stature, supporting a 'hold' recommendation for seasoned investors.

Keywords

Donaldson Company, SEC Filing, Proxy Statement, Annual Meeting, Corporate Governance, Executive Compensation, Director Election, Auditor Ratification, Financial Performance, Shareholder Return, Risk Management, Sustainability, Dividends, Share Repurchases

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.